SC
Saturna Capital Portfolio holdings
AUM
$7.76B
1-Year Est. Return
22.85%
1 Year Est. Return
+22.85%
AUM
$7.4B
AUM Growth
+$721M
(+11%)
Holding
164
Top Buys
| 1 | +$4.45M | |
| 2 | +$3.56M | |
| 3 | +$3.04M | |
| 4 |
Copart
CPRT
|
+$1.82M |
| 5 |
Boston Scientific
BSX
|
+$1.64M |
Top Sells
| 1 | +$86.7M | |
| 2 | +$56.1M | |
| 3 | +$23.2M | |
| 4 |
Union Pacific
UNP
|
+$22.2M |
| 5 |
Amgen
AMGN
|
+$18.7M |
Sector Composition
| 1 | Technology | 51.73% |
| 2 | Healthcare | 16.18% |
| 3 | Industrials | 13.74% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Consumer Staples | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Northern Trust
NTRS
$24.9B
| $211K | ﹤0.01% |
+1,667
|
|
||
152
Toronto Dominion Bank
TD
$143B
| $209K | ﹤0.01% |
+2,850
|
|
||
153
Wells Fargo
WFC
$268B
| $205K | ﹤0.01% |
+2,558
|
|
||
154
SiTime
SITM
$7.58B
| $205K | ﹤0.01% |
+960
|
|
||
155
Banco Santander
SAN
$160B
| $145K | ﹤0.01% |
+17,500
|
|
||
156
Dynavax Technologies
DVAX
$1.26B
| $135K | ﹤0.01% |
13,613
|
|
||
157
Iovance Biotherapeutics
IOVA
$909M
| $35.4K | ﹤0.01% |
20,553
|
|
||
158
Chevron
CVX
$306B
| – | – |
-1,200
|
|
||
159
Elastic
ESTC
$7.48B
| – | – |
-2,532
|
|
||
160
Edwards Lifesciences
EW
$49.7B
| – | – |
-13,410
|
|
||
161
lululemon athletica
LULU
$21.9B
| – | – |
-3,000
|
|
||
162
RxSight
RXST
$477M
| – | – |
-9,618
|
|
||
163
Zoetis
ZTS
$56.8B
| – | – |
-6,181
|
|
||
|
ORAN
164
DELISTED
Orange
ORAN
| – | – |
-20,000
|
|